The Thoracic and Cardiovascular Surgeon

We publish articles from internationally recognized thoracic and cardiovascular surgeons, cardiologists, anesthesiologists, physiologists, and pathologists.

[The Thoracic and Cardiovascular Surgeon @TCSurgeon]

Thank you to everyone who followed our🫁 and🫀 updates here over the years!
We are now closing this channel, but continuing our work and the conservation on LinkedIn: The Thoracic and Cardiovascular Surgeon & Reports.

Join us there! We are looking forward to staying connected.

[Tulio Caldonazo @TulioCaldonazo]

🫀💪🏻16 cardiac surgery residents kicked off the 3rd non-stop 36-hour “Strong German Hearts” course this weekend!

🫱🏻‍🫲🏼 In collaboration with national antiterror police, the program combines surgical training, teamwork and leadership

👏🏻 Thanks to @AbbottNews for making it possible

[The Thoracic and Cardiovascular Surgeon @TCSurgeon]

Minimally invasive lateral thoracotomies may cause severe postoperative pain and discomfort. Humpfle and colleagues describe an intraoperative intercostal cryo-neuronal pain block as one possibility for postoperative pain relief.

https://t.co/fQuELkhNwx

[The Thoracic and Cardiovascular Surgeon @TCSurgeon]

In obese patients, minimally invasive AVR poses challenges, including an increased risk of PPM.

Learn how BMI affects outcomes in this single-center analysis.

📖 https://t.co/Kce9CLVDuG

[The Thoracic and Cardiovascular Surgeon @TCSurgeon]

🫀✨ HTK Cardioplegia in Pediatrics: A Meta-Analysis

HTK solution = 💪 effective & 🛡️ safe for pediatric ‍ surgery!

⬇️ transfusions, fewer arrhythmias, & comparable efficacy vs. others.

See more: https://t.co/vAPlrznV8e

[The Thoracic and Cardiovascular Surgeon @TCSurgeon]

🫀 Surgical Mitral Valve Repair: High-Volume Centre Study (2002–2022)

📊 1,779 patients with MR.
✔️ Results: 30-day mortality 0.7%, 10-year survival ~72%.
💡 Minimally invasive techniques = great outcomes & durability!

See more: https://t.co/2YMUfCnYhd

[The Thoracic and Cardiovascular Surgeon @TCSurgeon]

🇨🇭 Tendyne Mitral Valve Implantation: Swiss Study

📊 75 patients (2015–2022) with severe mitral valve disease.
✔️ Success rate: 96%
🛡️ Low mortality (30-day: 6.7%)
💡 Conclusion: Safe & effective option for high-risk patients!

See more: https://t.co/UKiyUkMnWF

[The Thoracic and Cardiovascular Surgeon @TCSurgeon]

🫀 Minimally Invasive Mitral Valve Surgery (MIMVS) in Elderly (75+ yrs)

🔎 Study: 261 patients (2021–2022).
📉 Results: Low mortality (2.6% 30-day), low complications.
💡 Takeaway: MIMVS offers safe, effective outcomes for elderly patients!

See more: https://t.co/RfLKcv9Pq7

[Maximiliano Hernandez @max_hernandez26]

It was a pleasure to present the outcomes about the long-term survival of multi-arterial revascularization in Uruguay at the EACTS/STS/LACES Latin America Cardiovascular Surgery Conference in Buenos Aires.

👥 21.959 pts >18 yo, underwent CABG between 2002-2022.
MAG vs SAG

[Journal of Vascular Surgery @JVascSurg]

TAMBE vs PMEG? What is the future of complex endovascular aneurysm repair? #AAA #vascular Join us Wed. Dec 11 7pm EST Registration: https://t.co/L6lvNK3VRI

[Tulio Caldonazo @TulioCaldonazo]

🚨 Breaking ACS Research - Check out our new MA!

🩸💊 Crushed/chewed P2Y12 inhibitors lead to faster platelet inhibition without increasing bleeding risk

💡 9 RCTs, 1091 patients
✅ Safe for ACS management
📉 PRU significantly reduced in 1 hour

👉More: https://t.co/lipuZsXPEr

[The Thoracic and Cardiovascular Surgeon @TCSurgeon]

🫀 Infective Endocarditis Surgery

📊 30-day mortality: 17.4%
🔑 Risks: older age, 💔 cardiogenic shock, 🧪 chronic dialysis, NYHA IV, PVE, mitral valve surgery.

👩‍⚕️ Takeaway: Pre-op planning & 🛑 extra care save lives!

See more: https://t.co/NRi70iwhDe

[The Thoracic and Cardiovascular Surgeon @TCSurgeon]

🦠 Endocarditis Mortality Insights
- In-hospital mortality: 28.4%
- 1-year mortality: 40.9%
- Key pre-op risk factors: Age, EuroSCORE II, CAD and PM infection

📝Effective pre-op management of risk factors can improve outcomes in IE treatment

More: https://t.co/5ijSw9ynma

[The Thoracic and Cardiovascular Surgeon @TCSurgeon]

📝 Coronary angiography looks to be safe in selected patients with aortic valve endocarditis

📌Detects CAD in 54% of patients
📌No major complications 🚫🩸
📌BUT higher in-hospital mortality

More: https://t.co/s7xwWvHu4H

[Tulio Caldonazo @TulioCaldonazo]

🔍 Diagnosing Endocarditis: How accurate we are?

This diagnostic meta-analysis presents key findings from the modified Duke Criteria:
📊Sensitivity: 85%
✅Specificity: 98%
➕Positive LR: 40.2
➖Negative LR: 0.15

⬆️ High accuracy = better outcomes, less over- or misdiagnosis

[The Thoracic and Cardiovascular Surgeon @TCSurgeon]

📈 LDH is often linked to hemolysis in PVL, but this current study challenges this statement!

👉 TA-TAV valves: ⬆️ PVL yet ⬇️ LDH
👉 RDV valves: ⬆️ LDH, arrhythmias, but ⬇️ pacemaker need
💡 LDH may indicate valve flutter, not hemolysis.

See more: https://t.co/qzmg7qlyHK

[Jama Jahanyar,MD,PhD,FACS @JJahanyarMDPhD]

Our latest manuscript in JACC Case report: Rare Case of Valve-Sparing Root Reimplantation in a Patient With an An... https://t.co/7dSNrUNjMs

[AATS @AATSHQ]

.@Bptkramer, @EricRoselliMD et al found age is the strongest predictor of mechanical behavior of aneurysmal ascending #aorta. Log in to #JTCVS to see what's next for understanding the effects of age, ascending aortic length, and thickness: https://t.co/AjcMbTx3wx

#AortaEd

[Philipp Breitbart @Kardiophil]

Das 1. interventionelle Highlight 2025 - die @AGIKinterv Interventions-Akademie
👉24. & 25.1.25
👉Online-Edition
https://t.co/nX8AgLKp9D

@DGK_org @Herzmedizin_de @thiele_holger @KardiologieHH @GhanemAlexander @HolgerNef @Dr_Nele_ @O_Azizy_MD @KambisMashayek1

[Tulio Caldonazo @TulioCaldonazo]

🚨 Check out our new work published in @AmJCardio

🫀 CCTA proves to be a safe & reliable non-invasive alternative to ICA for coronary imaging before valve surgery

✅ No increased risk of mortality, AKI, MI, stroke, or MACE observed

👉 See more: https://t.co/G0N7heHC7O